Radcliffe Capital Management’s Isleworth Healthcare Acquisition Corporation Warrant ISLEW Stock Holding History

Radcliffe Capital Management’s Portfolio ISLEW Stock Details ISLEW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-300,000	Closed	-$2.99M	–	1245
2022 Q2	$2.99M	Hold	300,000	–	–	0.07%	490
2022 Q1	$2.97M	Hold	300,000	–	–	0.07%	466
2021 Q4	$2.95M	Hold	300,000	–	–	0.08%	397
2021 Q3	$2.95M	Hold	300,000	–	–	0.09%	336
2021 Q2	$2.94M	Hold	300,000	–	–	0.09%	354
2021 Q1	$2.91M	Buy	+300,000	New	+$143K	0.12%	339

Radcliffe Capital Management's ISLEW Position: Q3 2022 in Review

Radcliffe Capital Management sold out of Isleworth Healthcare Acquisition Corporation Warrant (ISLEW) in Q3 2022, closing a stake of 300,000 shares — an estimated $2.99M sold.

Radcliffe Capital Management first reported a position in ISLEW in Q1 2021 and held it in 6 quarters. The position peaked at $2.99M in Q2 2022. 0 funds tracked by Wall St. Rank hold ISLEW as of Q3 2022.

Radcliffe Capital Management reported no remaining Isleworth Healthcare Acquisition Corporation Warrant position as of Q3 2022 after selling out during the quarter.
Radcliffe Capital Management sold 300,000 Isleworth Healthcare Acquisition Corporation Warrant shares in Q3 2022, an estimated $2.99M.
Radcliffe Capital Management first reported a position in Isleworth Healthcare Acquisition Corporation Warrant in Q1 2021 and held it in 6 quarters.
Radcliffe Capital Management's Isleworth Healthcare Acquisition Corporation Warrant position peaked at $2.99M in Q2 2022.
0 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Warrant as of Q3 2022.

Based on Radcliffe Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.